Total number of Ontario screen-eligible women, 21-69 years old, who have completed at least one Pap test in a 42 month period

Identifying Pap tests:

• Pap tests were identified through CytoBase
• Pap tests were also identified using fee codes through OHIP:
• E430A: add-on to a003, a004, a005, a006 when pap performed outside hospital
• G365A: Periodic-pap smear
 
• E431A:When Papanicolaou smear is performed outside of hospital, to G394.
• G394A: Additional for follow-up of abnormal or inadequate smears
• L713A: Lab.med.-anat path,hist,cyt-cytol-gynaecological specimen
• L733A: Cervicovaginal specimen (monolayer cell methodology)
• L812A: Cervical vaginal specimens including all types of cellular abnormality, assessment of flora, and/or cytohormonal evaluation
• Q678A: Gynaecology – pap smear – periodic – nurse practitioners
• L643A: Lab Med - Microbiol - Microscopy - Smear Only, Gram/Pap Stain
• All Pap tests in CytoBase were counted, including those with inadequate specimens
• Each woman was counted once regardless of the number of Pap tests performed in a 42 month time frame

Total number of Ontario screen-eligible women, 21-69 years old in the reporting period

Exclusions

• Women diagnosed with an invasive cervical cancer prior to January 1st of  the reporting period, e.g. January 1st 2014 for 2014-2016; prior diagnosis of cervical cancer was defined as: ICD-O-3 codes C53, a morphology indicative of cervical cancer, microscopically confirmed with a path report
• Women who had a colposcopy and/or treatment within 2 years prior to January 1st of the reporting period
• Colposcopy and/or treatment were identified through OHIP, using the following   fee Codes:
•  Colposcopy
• Z731 - Initial investigation of abnormal cytology of vulva and/or vagina or cervix under colposcopic technique with or without biopsy(ies) and/or endocervical curetting
• Z787 - Follow-up colposcopy with biopsy(ies) with or without endocervical curetting
• Z730 - Follow-up colposcopy without biopsy with or without endocervical curetting
• Treatment
• Z732 - Cryotherapy
• Z724 - Electro
• Z766 - Electrosurgical Excision Procedure (LEEP)
• S744 - Cervix - cone biopsy - any technique, with or without D&C
• Z720 - Cervix Biopsy - with or without fulguration
• Z729 - Cryoconization, electroconization or CO2 laser therapy with or without curettage for premalignant lesion (dysplasia or carcinoma in-situ), out-patient procedure
• Women with a hysterectomy prior to January 1st of the reporting period
• Women with a hysterectomy were identified through OHIP, using the following fee codes:
• E862A – When hysterectomy is performed laparoscopically, or with laparoscopic assistance
• P042A – Obstetrics – labour – delivery – caesarean section including hysterectomy
• Q140A – Exclusion code for enrolled female patients aged 35-70 with hysterectomy
• S710A – Hysterectomy - with or without adnexa (unless otherwise specified)  – with omentectomy for malignancy
• S727A – Ovarian debulking for stage 2C, 3B or 4 ovarian cancer and may include hysterectomy
• S757A – Hysterectomy – with or without adnexa (unless otherwise specified) – abdominal – total or subtotal
• S758A – Hysterectomy - with or without adnexa (unless otherwise specified) – with anterior and posterior vaginal repair and including enterocoele and/or vault prolapse repair when rendered
• S759A - Hysterectomy - with or without adnexa (unless otherwise specified) – with anterior or posterior vaginal repair and including enterocoele and/or vault prolapse repair when rendered
• S762A - Hysterectomy - with or without adnexa (unless otherwise specified) – radical trachelectomy - excluding node dissection
• S763A - Hysterectomy - with or without adnexa (unless otherwise specified) – radical (Wertheim or Schauta) - includes node dissection
• S765A – Amputation of cervix
• S766A- Cervix uteri - Exc - cervical stump – abdominal
• S767A- Cervix uteri - exc - Cervical stump – vaginal
• S816A - Hysterectomy - with or without adnexa (unless otherwise specified) - vaginal